Company Search:
Advanced Search
Sponsored Links
CytRx Corporation Company Snapshot
CytRx Corporation operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares CytRx with three other companies in this sector in UNITED STATES : Seneca Biopharma IncXX (2018 sales of $260,000.00 ), Cardiff Oncology Inc ($378,325.00 of which 100% was Biological Product), and AIM ImmunoTech Inc ($367,000.00 ).

Sales Analysis. CytRx reported sales of $250,000.00 for the year ending December of 2018. This represents an increase of 150.0% versus 2017, when the company's sales were $100,000.00 .
  Stock Performance Chart for CytRx Corporation
  Stock Data: Recent Stock Performance:
  Current Price (1/15/2021): 2.40
(Figures in U.S. Dollars)
1 Week 29.7%   13 Weeks 152.6%  
4 Weeks 296.7%   52 Weeks 272.1%  
CytRx Corporation Key Data:
  Ticker: CYTR Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 250,000
(Year Ending Jan 2019).
Employees: 4
  Currency: U.S. Dollars Market Cap: 87,552,091
  Fiscal Yr Ends: December Shares Outstanding: 36,480,038
  Share Type: Common Closely Held Shares: 5,271,781
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.